PRESENTED IN EUROTOX 2023
Human kidney patient-derived organoids are a promising tool for modeling drug-induced nephrotoxicity and for assessing preclinical toxicity of immunotherapy
Factsheet
Explore the applications of HUB Organoids in immuno-oncology drug development
Blog: Ask the expert
Learn what the experts have to say about the applications of HUB Organoid-based immune cell co-cultures for immunotherapy. In this series, we interview our CSO Sylvia Boj, PhD and Director of pharmacaology at Gadeta, Andrea Bisso, PhD
On-demand presentation
Watch our CSO talk on the potential of patient-derived organoid platform to investigate gastrointestinal and liver toxicities